Adrian Hepner

468 total citations
6 papers, 213 citations indexed

About

Adrian Hepner is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Adrian Hepner has authored 6 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Neurology. Recurrent topics in Adrian Hepner's work include Neuroscience and Neuropharmacology Research (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Medicinal Plants and Neuroprotection (1 paper). Adrian Hepner is often cited by papers focused on Neuroscience and Neuropharmacology Research (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Medicinal Plants and Neuroprotection (1 paper). Adrian Hepner collaborates with scholars based in United States, China and United Kingdom. Adrian Hepner's co-authors include Ronald A. Thisted, Randolph B. Schiffer, Erik P. Pioro, Randall Kaye, Benjamin Rix Brooks, Daniel Wynn, Jeffrey L. Cummings, Laura E. Pope, Aziz Shaibani and Qingcheng Meng and has published in prestigious journals such as Annals of Neurology, Annals of Emergency Medicine and Journal of Alzheimer s Disease.

In The Last Decade

Adrian Hepner

6 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrian Hepner United States	4	113	54	41	39	38	6	213
Randall Kaye United States	5	166 1.5×	21 0.4×	43 1.0×	39 1.0×	90 2.4×	9	307
Keiichiro Tsunoda Japan	11	86 0.8×	77 1.4×	20 0.5×	25 0.6×	47 1.2×	24	257
Elisabetta Sette Italy	8	157 1.4×	20 0.4×	40 1.0×	23 0.6×	18 0.5×	17	255
Katharine Nicholson United States	10	189 1.7×	87 1.6×	29 0.7×	85 2.2×	18 0.5×	15	316
Jeffrey L. Seeburger United States	8	102 0.9×	134 2.5×	75 1.8×	42 1.1×	108 2.8×	11	312
Dave Hollander United States	5	91 0.8×	21 0.4×	41 1.0×	60 1.5×	28 0.7×	6	197
R G Hart United States	5	215 1.9×	38 0.7×	151 3.7×	21 0.5×	30 0.8×	5	321
Jonathan Vöglein Germany	9	29 0.3×	95 1.8×	46 1.1×	26 0.7×	62 1.6×	19	216
Clare Johnston United Kingdom	5	198 1.8×	31 0.6×	20 0.5×	104 2.7×	33 0.9×	5	247
P. De Deyn Belgium	7	218 1.9×	117 2.2×	36 0.9×	42 1.1×	112 2.9×	11	431

Countries citing papers authored by Adrian Hepner

Since Specialization

Citations

This map shows the geographic impact of Adrian Hepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Hepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Hepner more than expected).

Fields of papers citing papers by Adrian Hepner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Hepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Hepner. The network helps show where Adrian Hepner may publish in the future.

Co-authorship network of co-authors of Adrian Hepner

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Hepner. A scholar is included among the top collaborators of Adrian Hepner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Hepner. Adrian Hepner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Shi, Yun, Lei Zhang, Xue Gao, et al.. (2020). Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice. Journal of Alzheimer s Disease. 76(4). 1375–1389. 19 indexed citations

2.

Shi, Yun, Xue Gao, Jing Zhang, et al.. (2019). P2‐069: INTRANASAL DANTROLENE AS A DISEASE‐MODIFYING DRUG IN ALZHEIMER 5XFAD MICE. Alzheimer s & Dementia. 15(7S_Part_11). 3 indexed citations

3.

Cheung, Eric, William J. Edenfield, Bassam Mattar, et al.. (2017). Safety and Pharmacokinetics of Bendamustine Rapid‐Infusion Formulation. The Journal of Clinical Pharmacology. 57(11). 1400–1408. 3 indexed citations

4.

Hepner, Adrian & Marna Rayl Greenberg. (2017). 95 Safety and Efficacy of Dantrolene Sodium (250 mg/5 mL) in Patients With Exertional Heat Stroke. Annals of Emergency Medicine. 70(4). S39–S39. 2 indexed citations

5.

Shaibani, Aziz, Laura E. Pope, Ronald A. Thisted, & Adrian Hepner. (2012). Efficacy and Safety of Dextromethorphan/Quinidine at Two Dosage Levels for Diabetic Neuropathic Pain: A Double-Blind, Placebo-Controlled, Multicenter Study. Pain Medicine. 13(2). 243–254. 39 indexed citations

6.

Pioro, Erik P., Benjamin Rix Brooks, Jeffrey L. Cummings, et al.. (2010). Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect. Annals of Neurology. 68(5). 693–702. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact